Tópico: Uma Saída para o Câncer - Sodré / Sang Lee

[Sergiomgbr]

Nem sabia que havia um modo de impressão.

Impressionante, sério!

[Gigaview]

Impressionante mesmo se tivesse um modo de televisão Cinemax 3D com som Dolby ou coisa parecida com os posts levitando em nuvens de tópicos.

[Buckaroo Banzai]

Clique em "imprimir".

Eu acho que nunca tinha percebido esse botão/link.

[Gigaview]

Cancer tumours destroyed by berry found in Queensland rainforest
Drug derived from the fruit of the blushwood tree kills cancerous tumours long-term in animals in 70% of cases


Scientists have managed to destroy cancerous tumours by using an experimental drug derived from the seeds of a fruit found in north Queensland rainforests.

The drug, called EBC-46, was produced by extracting a compound from the berry of the blushwood tree, a plant only found in specific areas of the Atherton Tablelands.

A single injection of the drug directly into melanoma models in the laboratory, as well as into cancers of the head, neck and colon in animals, destroyed the tumours long-term in more than 70% of cases, the study’s lead author, Dr Glen Boyle, said.

“In preclinical trials we injected it into our models and within five minutes, you see a purpling of the area that looks like a bruise,” Boyle, from the QIMR Berghofer Medical Research Institute said.

“About 24 hours later, the tumour area goes black, a couple of days later you see a scab, and at around the 1.5 week mark, the scab falls off, leaving clean skin with no tumour there. The speed certainly surprised me.”

Researchers believe the drug triggers a cellular response which cuts off the blood supply to the tumour by opening it up.

“That’s why we see a bruise-like situation forming in the tumour,” Boyle said. “This seems to lead to an activation of the body’s own immune system which then comes in and cleans up the mess.”

It has been used by veterinarians in about 300 cases of cancer in companion animals including dogs, cats and horses.

There was no evidence EBC-46 would be effective to treat cancers that had spread to other parts of the body, known as metastatic cancers, Boyle said.



The drug is being developed as a human and veterinary pharmaceutical through QBiotics, a subsidiary of the company which discovered the drug, called EcoBiotics. The company is also examining the potential for a blushwood plantation.

Ethical approval was recently granted for phase 1 human clinical trials, but even if those proved successful, it was unlikely the drug would replace conventional chemotherapy treatment, Boyle said.

“Chemotherapy is still used because it is very effective for a lot of people,” he said. “But EBC-46 could perhaps be used in people who, for some reason, chemotherapy doesn’t work [for], or for elderly patients whose body can’t sustain another round of chemotherapy treatment.”

The preclinical trial was funded by QIMR Berghofer and the National Health and Medical Research Council and the results were published in the journal PLOS One.

http://www.theguardian.com/society/2014/oct/08/cancer-tumours-destroyed-by-berry-queensland-rainforest

Cancer Cure Found? Clinical Trials Approved After a Breakthrough Discovery

A very promising and encouraging news for cancer patients all over the world was revealed recently. Researchers at the QIMR Berghofer Medical Research Institute made a breakthrough discovery, regarding the cure for cancer and the clinical trials of the drug were approved. They discovered that the chemical, which they found in a rare plant from Australia, has the ability to eat cancerous tumors and completely remove them within just a few days. Does this mean that the cancer cure has finally been discovered?

Researchers have successfully managed to destroy cancerous tumors by using an experimental medicine, which is derived from the seeds of a fruit, found in the rain-forests in north Queensland. The experimental drug is called EBC-46 and it was produced with an extraction of a compound from the berry of the Blushwood tree. This plant is only found in specific areas of the Atherton Tablelands, Australia.

Dr. Glen Boyle from the QIMR Berghofer Medical Research Institute, who is the lead author of the study, said that in more than 70% of cases, one single injection of the EBC-46 drug directly into melanoma models in the laboratory, as well as into cancers of the neck, colon and head in animals, destroyed the tumors long-term.

Boyle said that in their pre-clinical trials, they injected the EBC-46 drug into their models and within five minutes, they could see a purpling of the area that looked like a bruise. About one day later, the tumor area went black, a couple of days later they saw a scab and after about one and a half week later, the scab fell off, leaving clean skin with no tumor there. Dr. Boyle admitted that the speed of the healing process certainly surprised him.

Scientists believe that the EBC-46 drug triggers a cellular response, which cuts off the blood supply to the tumor by opening it up. Boyle said that this is the reason why they saw a situation that looked like a bruise, forming in the tumor. This seems to be leading to the activation of the body’s own immune system, which then kicks in and cleans up the mess.

The experimental drug was used by veterinarians in almost 300 cases of cancer in companion animals, including horses, cats and dogs. However, there is no evidence yet that the EBC-46 drug would be effective in treating metastatic cancers, which are the cancers, which have already spread to other parts of the body.

EBC-46 is being developed as a veterinary and human pharmaceutical through QBiotics, which is a subordinate of the company that discovered the drug, called EcoBiotics. This company is also examining if there is a potential for a Blushwood plantation.

Dr. Boyle said that the ethical approval was recently granted to begin with phase 1 of human clinical trials, however, even if they prove to be successful, it is highly unlikely that the drug will replace the conventional chemotherapy treatment.

Since it is very effective for many people, chemotherapy is still being used. However, the EBC-46 drug could perhaps be used in people for which, for some reason, the chemotherapy does not work. This drug could also be used for elderly patients, whose body cannot sustain another round of chemotherapy treatment.

QIMR Berghofer and the National Health and Medical Research Council funded the pre-clinical trial and its results were published in the PLOS One journal. Since there are more and more cancer patients every year, this is most certainly a very exciting and most of all, encouraging news for all of them.


Read more at http://guardianlv.com/2014/10/cancer-cure-found-clinical-trials-approved-after-a-breakthrough-discovery/#qZcRqTVdT8yoBu5g.99

[Cientista]

" Ethical approval was recently granted for phase 1 human clinical trials, but even if those proved successful, it was unlikely the drug would replace conventional chemotherapy treatment, Boyle said.

“Chemotherapy is still used because it is very effective for a lot of people,” he said. “But EBC-46 could perhaps be used in people who, for some reason, chemotherapy doesn’t work [for], or for elderly patients whose body can’t sustain another round of chemotherapy treatment.” "


E por que não usar quimioterapia e outras técnicas consagradas, tudo tão debilitante e colateralizado, exatamente naqueles que não responderem a esse milagre recém-descoberto que  mostra em horas se vai funcionar ou não (caso seja aprovado)? Essa conversa é exatamente a mesma dos exploradores das medicinas alternativas.


Esse pessoal... Brincando com coisa séria, sempre. Mais uma "notícia"...  ...para os arquivos intermináveis. É cômico, mas aqui o Cientista não vai rir. Desculpem.